Tamoxifen bipolar disorder
Ellis mj, coop a, singh b, et al letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for erbb-1- and or erbb-2-positive, estrogen receptor-positive primary breast cancer evidence from a phase iii randomized trial.
Read more
